Table 1. Summary of Tumor Incidence.
| Genotype | Injection Site | Latency Period | Mice with Phenotype (%) |
| p53 flox/flox | Bursa | 3 months | 0/13 |
| Bursa | 6 months | 2/7 (29) Bursal Cyst | |
| Oviduct | 3 months | 0/15 | |
| Oviduct | 6 months | 1/5* | |
| Smad2DN; p53 flox/flox | Bursa | 3 months | 2/6 (33) Teratoma |
| Bursa | 6 months | 1/7 (14) Bursal Cyst | |
| Oviduct | 3 months | 0/11 | |
| Oviduct | 6 months | 0/6 | |
| Smad2DN+/+ | N/A | 2–6 months | 5/18 (28) Teratoma |
Intraoviductal injection with leakage into the bursa.